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The development of obesity not only depends on the balance between food intake and 
caloric utilization but also on the balance between white adipose tissue, which is the 
primary site of energy storage, and brown adipose tissue, which is specialized for energy 
expenditure. In addition, some sites of white fat storage in the body are more closely linked 
than others to the metabolic complications of obesity, such as diabetes. In this Review, 
we consider how the developmental origins of fat contribute to its physiological, cellular, 
and molecular heterogeneity and explore how these factors may play a role in the growing 
epidemic of obesity.We are in the midst of a worldwide epidemic of obesi-
ty—a major factor in the development of common med-
ical conditions such as type 2 diabetes, dyslipidemias, 
fatty liver, cardiovascular disease, Alzheimer’s disease, 
gallstones, and even some cancers. These conditions 
occur in large part as a result of insulin resistance 
induced by obesity and the fact that adipose tissue not 
only serves to store energy but is also the body’s larg-
est endocrine organ, secreting hormones, cytokines, 
and proteins that affect the function of cells and tissues 
throughout the body.
What Causes Obesity?
Obesity develops when energy intake exceeds energy 
expenditure. Although the number of fat cells can 
increase throughout life (Prins and O’Rahilly, 1997), 
individuals with adult-onset obesity in general exhibit 
increased adipocyte size, whereas individuals with 
early-onset obesity have both adipocyte hypertrophy 
and hyperplasia (Hirsch and Batchelor, 1976). Fat dis-
tribution also plays an important role in metabolic risk. 
Increased intra-abdominal/visceral fat (central or apple-
shaped obesity) promotes a high risk of metabolic dis-
ease, whereas increased subcutaneous fat in the thighs 
and hips (peripheral or pear-shaped obesity) exerts little 
or no risk (Kissebah and Krakower, 1994) (Figure 1, top). 
Both fat mass and distribution can be measured by mag-
netic resonance imaging (MRI) and Dual-Energy X-Ray 
Absorptiometry (DEXA), but for most purposes, sim-
pler surrogate measurements such as body mass index 
(BMI = weight in kg/height in meters2) and waist-hip ratio 
(WHR) or waist circumference are used.
The past two decades have shed considerable light 
on the role of factors controlling food intake and energy 
expenditure in body weight regulation (Flier, 2004) and 
on the transcriptional control and cell biology underly-242 Cell 131, October 19, 2007 ©2007 Elsevier Inc.ing conversion of preadipocytes to adipocytes (Farmer, 
2006; Rosen and MacDougald, 2006). Surprisingly little 
is known, however, about the developmental origins of 
adipose tissue; the control of brown versus white preadi-
pocyte commitment; the control of the relative amounts 
and functional heterogeneity among white fat cells in 
different depots; and the exact pathways and intermedi-
ates between the embryonic stem cell and the mature 
fat cell. It is these processes that are the primary focus 
of this Review.
Adipocytes and the Adipose Organ
Virtually all animal species, from C. elegans to Homo 
sapiens, have found a way to store excess energy in the 
form of fat for future needs. C. elegans store fat in intesti-
nal epithelium (McKay et al., 2003) and sharks store fat in 
the liver (Van Vleet et al., 1984)—both tissues of endoder-
mal origin. But in most species, fat storage occurs in a 
mesodermal tissue, namely white adipose tissue (WAT). 
WAT location varies between species. For invertebrates, 
amphibians, and many reptiles, the largest fat stores are 
intra-abdominal; in seals and whales, most fat is subcu-
taneous, whereas mammals and birds have both intra-
abdominal and subcutaneous WAT. This does not simply 
reflect an evolutionary adaptation for thermal insulation, 
as similar fat distribution is observed in arctic and tropical 
mammals of similar body mass (Pond, 1992). In humans, 
WAT is dispersed throughout the body with major intra-
abdominal depots around the omentum, intestines, and 
perirenal areas, as well as in subcutaneous depots in 
the buttocks, thighs, and abdomen (Figure 2, bottom). In 
addition, WAT can be found in many other areas, includ-
ing in the retro-orbital space, on the face and extremi-
ties, and within the bone marrow. Some adipose tissue 
is responsive to sex hormones, such as adipose tissue 
in the breasts and thighs, whereas other depots, such 
as fat on the neck and upper back, are more responsive 
to glucocorticoids—forming a so-called “buffalo-hump” 
in humans with an excess of glucocorticoids, such as 
in Cushing’s disease. Interestingly, the acquired form 
of lipodystrophy associated with treatment for HIV pro-
duces a similar kind of buffalo-hump (Miller et al., 1998). 
Fat distribution, even in thin individuals with steady body 
weight and stable BMI, changes with age, decreasing in 
retro-orbital fat and subcutaneous fat and increasing  in 
intra-abdominal fat.
Genetics play an important role in both obesity and 
distribution of WAT. Twin and population studies have 
revealed that both BMI and WHR are heritable traits, 
with genetics accounting for 30%–70% of the variabil-
ity (Nelson et al., 2000). For exam-
ple, such genetic control of body 
fat distribution is evident in Hot-
tentot/Khoisan women, who have 
marked accumulation of fat in the 
buttocks (steatopygia). Striking 
differences in WAT distribution 
can also be observed in individu-
als with heritable forms of partial 
lipodystrophy (Agarwal and Garg, 
2006) (see below).
In mammals the adipose organ 
is composed not only of white adi-
pocytes, which are the primary 
site of triglyceride/energy storage, 
but also brown adipocytes, which 
are important in both basal and 
inducible energy expenditure in the 
form of thermogenesis (Figure 2). 
This occurs through expression of 
uncoupling protein-1 (UCP-1), a 32 
kDa protein found in the inner mito-
chondrial membrane, that allows 
dissipation of the proton electro-
chemical gradient generated by respiration in the form of 
heat (Cannon and Nedergaard, 2004). In rodents, brown 
adipose tissue (BAT) is most abundant in the neonatal 
period and is most concentrated in the interscapular 
region. Brown adipocytes can also be found in other 
areas, including typical WAT depots, following cold expo-
sure (Cinti, 2005). Although some “warm-bodied” fishes 
(such as swordfish) maintain brain temperatures higher 
than the environment due to the presence of brown fat-
like “heater cells” around the brain, BAT itself develops 
relatively late in the course of evolution in parallel with 
the development of homeothermy and the capacity for 
nonshivering thermoregulation. Boney fish, such as carp 
(Cyprinus carpio), express UCP-1 in the liver, and in 
Figure 1. Fat Distribution Influences 
Risks Associated with Obesity in 
Humans
(Top) Obesity is the consequence of an ex-
cess in fat accumulation and is defined by 
a body mass index of ≥ 30. Fat distribu-
tion can be estimated by measurements of 
the ratio of waist to the hip circumference 
(WHR). Obese individuals with low WHR, 
(subcutaneous or pear-shaped obesity) 
are at low risk for metabolic complications 
of obesity, whereas individuals with a high 
WHR (visceral or apple-shaped obesity) 
are at high risk for these complications 
(Kissebah and Krakower, 1994). (Bottom) 
In humans, depots of white adipose tissue 
are found in areas all over the body, with 
subcutaneous and intra-abdominal depots 
representing the main compartments for fat 
storage. Brown adipose tissue is abundant 
at birth and still present in adulthood but to 
a lesser extent.Cell 131, October 19, 2007 ©2007 Elsevier Inc. 243
Figure 2. Evolution of Adipose Tissue Depots
Adipose tissue distribution and fat storage have changed dramatically with the process of evolution. In the worm C. elegans fat is stored in the 
intestine, whereas Drosophila have a defined fat body. Sharks are devoid of adipose tissue and use their liver to store fat. Intra-abdominal white 
adipose tissue (WAT) becomes apparent, coinciding with the presence of leptin in boney fishes, such carp (Cyprinus carpio), amphibians and fast-
moving reptiles. Differentiation of subcutaneous and internal WAT occurs in higher species, such as birds and mammals, exemplified here by the 
chicken (Gallus gallus domesticus), mouse (Mus musculus), and human (Homo sapiens). Thermoregulation also appears in the course of evolution 
but independently of the appearance of brown adipose tissue (BAT). Estimated to have emerged 150 millions years ago, BAT is only present in higher 
mammals, although UCP-1 expression appears independently of BAT in boney fish. Endotherm refers to an animal that produces its own heat from 
within versus ectotherm, an animal that does not. These terms are interchangeable with homeotherm, i.e., an animal that can maintain a specific 
body temperature or is warm blooded versus poikilotherm, i.e., an animal that has a body temperature that varies with the ambient temperature or 
is cold blooded.contrast to mammals, UCP-1 expression is diminished 
in response to cold exposure (Jastroch et al., 2005). 
So far no tissue resembling BAT has been reported in 
amphibians or reptiles, although expression of UCP-4 
has been found in frog oocytes and in head muscle and 
the pharynx of C. elegans, where it negatively regulates 
ATP production (Iser et al., 2005). Interestingly, birds are 
homeotherms, but devoid of BAT, and depend on UCP 
expression in muscle for nonshivering thermoregulation 
(Mozo et al., 2005).
In human fetuses and newborns, BAT is found in axil-
lary, cervical, perirenal, and periadrenal regions (Can-
non and Nedergaard, 2004) but decreases shortly after 
birth and has traditionally been considered insignificant 
in adults, except perhaps in patients with pheochro-
mocytoma, where adrenergic activity is extremely high 
(English et al., 1973), or in outdoor workers in northern 
climes subject to prolonged cold exposure (Huttunen et 
al., 1981). However, recent morphological and scanning 
studies have shown that brown fat in humans may not 
be as rare as once believed. Indeed, [18F]-2-fluoro-D-2-
deoxy-D-glucose (FDG) positron emission tomography 
(PET) can detect areas of metabolically active brown 
fat in the cervical, supraclavicular, axillary, and paraver-
tebral regions of normal individuals (Nedergaard et al., 
2007) (Figure 1, bottom). UCP-1 mRNA can be detected 
in human WAT and is further induced by the antidiabetic 
drugs thiazolidinediones (Digby et al., 1998), suggesting 
some admixture of BAT in WAT depots.244 Cell 131, October 19, 2007 ©2007 Elsevier Inc.Although it is unclear to what extent BAT might play a 
role in energy balance in adult humans, Rothwell and Stock 
(1983) have estimated that as little as 50 g of BAT could 
account for 20% of daily energy expenditure, if maxi-
mally stimulated. Furthermore, up to 24% of the increase 
in metabolism in lean men produced by ephedrine has 
been attributed to BAT (Astrup et al., 1985). It has been 
suggested that the age-related decline in thermogenesis 
and regulatory energy expenditure in humans and rodents 
is associated with a reduction in the amount of functional 
BAT. In rodents, targeted ablation of BAT results in diet-
induced obesity, diabetes, and hyperlipidemia (Lowell et 
al., 1993). UCP-1-deficient mice also exhibit increased sus-
ceptibility to age- and diet-related obesity (Kontani et al., 
2005). Recently, depots of UCP-1-positive brown adipo-
cytes have been identified, interspersed between skeletal 
muscle bundles in the legs of an obesity-resistant strain of 
mice, suggesting that “ectopic brown adipocytes” may play 
an important role in the regulation of whole-body energy 
homeostasis (Almind et al., 2007). The potential of induc-
ing even small amounts of brown fat in adult humans could 
provide a new approach to the treatment and/or prevention 
of obesity and its metabolic complications.
The Origin of Adipose Tissue
Lineage Determination
Adipose tissue, like muscle and bone, is generally 
regarded as having a mesodermal origin. However, this 
may be an oversimplification because precise lineage 
tracing studies have not been performed. The formation 
of the mesoderm begins with the migration of a layer of 
cells between the primitive endoderm and ectoderm. This 
layer spreads along the anteroposterior and dorsoventral 
axes of the developing embryo giving rise to the axial, 
intermediate, lateral plate, and paraxial mesoderm. The 
paraxial mesoderm, after its segmentation into somites, 
gives rise to the axial skeleton and muscles of the trunk. 
The lateral plate mesoderm generates the skeleton and 
muscles of the limbs. Interestingly, the bones and mus-
cles of the skull and face appear to be of ectodermal ori-
gin, specifically the neural crest (Bronner-Fraser, 1994). 
Recently, neural crest stem cells have been reported to 
be able to differentiate into adipocytes in culture (Billon 
et al., 2007). Each of these regions are presumed to give 
rise to local adipose tissue. Such a developmental origin 
is consistent with the occurrence of various forms of par-
tial lipodystrophy and with the differential expression of 
genes involved in development and patterning between 
different fat depots. Brown adipose tissue also appears 
to be of mesodermal origin. Interestingly, when meso-
derm from a 9-day-old rat embryo is engrafted below the 
kidney capsule of an adult rat, it develops only into BAT 
(Loncar, 1992). Using genetic fate mapping under control 
of the homeobox transcription factor Engrailed 1 (En1), 
Atit et al. (2006) have shown that interscapular brown fat 
is derived from the paraxial mesoderm.
Mesenchymal stem cells (MSCs) were initially iden-
tified in postnatal human bone marrow and have been 
used to model differentiating mesoderm. MSCs are 
capable of differentiating into adipo-
cytes, osteoblasts, chondrocytes, 
myoblasts, and connective tissue. 
Although the exact number of interme-
diate stages between a mesodermal/
mesenchymal stem cell and a mature 
adipocyte is uncertain, it is believed 
that the MSC gives rise to a common early precursor 
(adipoblast), which in turn develops into committed white 
and brown preadipocytes that under appropriate stimu-
latory conditions differentiate into mature adipocytes of 
different types (Figures 3 and 4). However, as none of 
these precursor cells possesses any unique morpho-
logical characteristics or gene expression markers, it is 
not clear if separate adipoblasts and/or preadipocytes 
for brown and white fat exist or if there are different white 
preadipocytes for different white adipose depots. Nor is 
it known what factors control progress of the early MSC 
down these differentiation pathways. In contrast to stud-
ies of other well-defined cell lineages, use of monoclonal 
antibodies and cell sorting in tracing adipocyte develop-
ment have been severely limited by both the nature of the 
cells and reagent availability.
The process of terminal adipocyte differentiation dur-
ing which preadipocytes mature into adipocytes has 
been extensively studied in mouse 3T3-L1 and 3T3-
F442A cell lines and immortalized brown preadipocyte 
cell lines (Rosen and Spiegelman, 2000). The transition 
from preadipocyte to adipocyte involves four stages: 
growth arrest, clonal expansion, early differentiation, 
and terminal differentiation. These stages are orches-
trated by a transcriptional cascade involving the nuclear 
receptor PPARγ and members of the C/EBPs family 
(Farmer, 2006). PPARγ plays an important role in adi-
pogenesis and has been shown to be necessary and 
sufficient for adipocyte differentiation (Rosen and Mac-
Dougald, 2006). PPARγ also appears to be required for 
Figure 3. Development of Mesenchymal/
Mesodermal Derivatives
Mesenchymal stem cells (MSCs) develop from 
the mesoderm and then commit into different lin-
eages influenced by a number of factors. BMPs 
through their intracellular mediators (Smad pro-
teins) can trigger MSCs to enter the osteogenic 
and/or adipogenic lineage, while preventing 
commitment into the myogenic lineage. Intracel-
lular proteins, such as TAZ and Schnurri-2 (Shn), 
modify the action of BMP in the determination 
of the osteogenic and adipogenic lineages. In 
addition, the action of BMPs can be modulat-
ed by Noggin, Nodal, and glypican 3. Wnt and 
Hedgehog proteins are important for MSC com-
mitment in myogenic and osteogenic lineages 
and prevent commitment in the adipogenic lin-
eage. Once committed, MSC give rise to undif-
ferentiated precursors (osteoblast, adipoblast/
preadipocyte, and myoblast), which upon the 
expression of key transcription factors enter a 
differentiation program to acquire their specific 
functions.Cell 131, October 19, 2007 ©2007 Elsevier Inc. 245
Figure 4. Molecular Signature of 
 Adipocyte Lineagesmaintenance of the terminal differentiated state of adi-
pocytes, and expression of a dominant-negative PPARγ 
in differentiated 3T3-L1 cells induces dedifferentiation 
with loss of lipid accumulation and decreased expres-
sion of adipocytes markers. Likewise, inducible knock-
out of PPARγ in mature adipocytes in vivo leads to death 
of both brown and white adipocytes. However, mice with 
adipocyte-specific knockout of PPARγ generated using 
an aP2 promoter-Cre still have some white fat develop-
ment. Two isoforms of PPARγ (PPARγ1 and PPARγ2) are 
generated by alternative splicing and promoter usage of 
the Pparg gene. Although both are expressed in adipo-
cytes, PPARγ2 has been regarded as a specific marker 
of fat. Mice with germline knockout of PPARγ2, however, 
still have some WAT, suggesting that PPARγ1 can com-
pensate for loss of PPARγ2. PPARγ2 null mice are also 
insulin resistant, suggesting a role for this transcription 
factor in maintaining insulin sensitivity independent of 
its effects on adipogenesis (Rosen and 
MacDougald, 2006).
The C/EBP family consists of five dif-
ferent members, C/EBPα, C/EBPβ, C/
EBPδ, C/EBPγ, and CHOP. Sequential 
expression of these factors is observed 
during adipocyte differentiation, in 
which the early expression of C/EBPβ 
and C/EBPδ promotes expression of 
C/EBPα and PPARγ (Farmer, 2006). C/
EBPβ-deficient mice exhibit reduced 
adipose mass, whereas mouse embry-
onic fibroblasts (MEFs) lacking C/EBPβ 
are still capable of differentiating into 
adipocytes in vitro, albeit with reduced 
efficiency. Indeed, some adipose tis-
sue can be found in mice deficient of 
both C/EBPβ and C/EBPδ.
In contrast, C/EBPα is required for white adipogen-
esis. C/EBPα-deficient mice that have been rescued 
from death by re-expression of C/ebpa in liver show an 
absence of subcutaneous, perirenal, and epididymal 
WAT but near normal mammary WAT, with somewhat 
hypertrophied BAT (Linhart et al., 2001). Although both 
C/EBPα and PPARγ control adipocyte differentiation, 
PPARγ appears to be dominant. Thus, forced expres-
sion of PPARγ can rescue the differentiation of MEFs 
lacking C/EBPα to adipocytes, whereas forced expres-
sion C/EBPα does not rescue differentiation in MEFs 
lacking PPARγ.
What Defines a Preadipocyte and an Adipocyte?
Although some lipid accumulation can occur in many 
cell types, including macrophages, hepatocytes, and 
muscle, adipocytes are morphologically different from 
other cells due to the presence of large lipid droplets 
surrounded by a specific protein, perilipin (Greenberg et 
Adipocytes arise from mesenchymal/meso-
dermal stem cells by a sequential pathway of 
differentiation. When triggered by appropriate 
developmental cues, MSCs become committed 
to the adipocyte lineage. Although some stages 
are still not clearly defined, this differentiation 
pathway presumably involves a common preadi-
pocyte or adipoblast, which has the capacity to 
differentiate into white or brown preadipocytes. 
The proteins and genes that represent potential 
molecular markers in cells within the adipocyte 
lineage are marked with a “+” or “−“ sign indi-
cating the relative levels of expression of these 
markers. The table summarizes the relative ex-
pression levels of various developmental and 
patterning genes in different fat depots in both 
humans and mice. The data have been com-
piled from Vohl et al. (2004), Cantile et al. (2003), 
Gesta et al. (2006), and Tchkonia et al. (2007), as 
well as our unpublished data. The relative levels 
of expression have been graded from absent (−) 
to high (+++).246 Cell 131, October 19, 2007 ©2007 Elsevier Inc.
al., 1991). The droplets are usually unilocular in WAT and 
multilocular in BAT. Mature adipocytes in WAT and BAT 
are also marked by the presence of PPARγ2, markers 
of terminal differentiation (such as Glut4 and fatty-acid 
synthase), and insulin-regulated glucose uptake and 
metabolism (Rosen and MacDougald, 2006). In addition, 
WAT is characterized by the presence of leptin, whereas 
BAT is distinguished by the existence of UCP-1 (Figure 
4). However, white or brown preadipocytes are indistin-
guishable from any cell type with a fibroblast-like mor-
phology, making them difficult to identify and study.
The only widely accepted marker of preadipocytes is 
preadipocyte factor 1 (Pref-1; also known as DLK-1 or 
Drosophila Homolog-like 1) (Villena et al., 2002). Pref-1 is 
expressed at high levels in both white and brown preadi-
pocytes, and expression markedly decreases upon dif-
ferentiation. Pref-1, however, is not unique to the preadi-
pocyte and is also expressed in placenta, pituitary, 
adrenal cortex, fetal liver, and pancreatic islet cells.
Pref-1/DLK-1 belongs to the Notch/Delta/Serrate fam-
ily of proteins that have epidermal growth factor-like 
repeats. Pref-1 is synthesized as a transmembrane pro-
tein and is cleaved to generate a soluble 50 kDa form 
that acts to inhibit adipocyte differentiation. Mice lacking 
Pref-1 show accelerated fat deposition, whereas mice 
overexpressing soluble Pref-1 in adipose tissue exhibit 
decreased fat mass and adipocyte marker expression. 
Pref-1/DLK-1 is in an imprinted region of the genome, 
and in sheep, the genetic disorder termed callipyge, 
which changes imprinting, leads to decreased fat depo-
sition, hindlimb muscular hypertrophy, and increased 
feeding efficiency (Charlier et al., 2001).
Other putative preadipocyte markers are the type VI 
collagen alpha 2 chain (COL6A2) (Ibrahimi et al., 1993) 
and a secretory protein related to the Wnt antagonist 
Frzb, namely FRP2/SFRP2 (Hu et al., 1998). The latter 
is particularly abundant in subcutaneous fat (Gesta et 
al., 2006). Like Pref-1, both are more highly expressed 
in undifferentiated preadipocytes and reduced in mature 
adipocytes. However, neither is adipose tissue specific.
In addition to adipocytes, fat pads contain preadi-
pocytes, vascular cells, nerves, macrophages, and 
fibroblasts. When adipose tissue is dispersed, these 
latter cells are collectively referred to as the stro-
movascular fraction. Using cell-sorting approaches, 
Sengenes et al. (2005) isolated preadipocytes from 
human stromovascular fraction. These CD34+/CD31− 
cells displayed features distinct from the adult mesen-
chymal and hematopoietic stem cells. This approach, 
however, is still in its infancy, and, at present, the only 
definitive criteria that identifies preadipocytes is their 
subsequent ability of the cells to accumulate lipid and 
develop a pattern of adipocyte marker gene expres-
sion (Figure 4). It is also important to realize that even 
cell lines considered good models of WAT do not 
express all WAT markers. For example, 3T3-L1 cells 
produce little, if any, leptin compared to normal white 
adipocytes.Signals Inducing Mesodermal and Adipose 
Development
Vertebrate embryonic patterning and evolution of meso-
dermal tissues such as fat are controlled by several 
conserved developmental signaling systems, including 
effects of Nodal, wingless (Wnt), bone morphogenetic 
proteins (BMPs), and fibroblast growth factors (FGFs). 
The exact effects of these factors depend on concentra-
tion, stage of differentiation, as well as extrinsic factors, 
such as matrix-cell and cell-cell interactions, the pres-
ence of vasculature, and the level and type of innervation 
(Figure 3).
Bone Morphogenetic Proteins, Nodal, and the 
SMAD Pathway
BMPs are members of the transforming growth factor-β 
(TGF-β) superfamily and play a critical role in the com-
mitment of MSCs into the adipocyte lineage. There are 14 
members in the BMP family (BMP-2 to BMP-15). Bmp4 
has been shown to stimulate the differentiation of MSC to 
adipocytes (Tang et al., 2004), and mice with disruption of 
the Bmp4 gene die between E6.5 and E9.5 and show little 
or no mesodermal differentiation or expression of the early 
mesodermal marker brachyury (T) (Winnier et al., 1995). In 
addition, several mouse models with null mutations ablat-
ing either ligands, receptors, or downstream components 
of the BMP signaling system showed defects in meso-
derm formation, providing indirect evidence for a role for 
BMPs in the development of adipose tissue (Tseng and 
He, 2007). Bmp2 expression during early development 
appears to be limited to the visceral endoderm and the 
extra-embyonic mesoderm, and BMP-2 and BMP-7 have 
been shown to promote osteogenic and inhibit adipo-
genic differentiation of MSCs, although these effects are 
variable depending on concentration (Wang et al., 1993; 
Asahina et al., 1996) (Figure 3). Mice with disruption of 
the Schnurri-2 gene, a zinc finger-containing protein that 
works in cooperation with Smad 1 and 4 and C/EBPα in 
induction of PPARγ expression following BMP-2 stimula-
tion, have reduced white and, to a lesser extent, brown fat 
mass (Jin et al., 2006).
Fibroblast Growth Factors
The FGF system consists of four receptors and at least 23 
growth factors, a number of which have been implicated 
in development or differentiation of mesodermal tissues. 
FGFs 1, 10, 16, and 19 have specifically been implicated 
in adipose development. FGF-10 mRNA is most abundant 
in WAT, where it is expressed primarily in preadipocytes 
(Yamasaki et al., 1999). FGF-10 shows significant mitogenic 
activity for primary preadipocytes but does not affect their 
differentiation, suggesting that it may act as a growth factor 
for WAT preadipocytes. Conversely, FGF-16 is expressed 
predominantly in BAT and might be important for embry-
onic development of BAT (Konishi et al., 2000). Transgenic 
mice overexpressing FGF-19 have increased BAT mass 
and reduced susceptibility to diet-induced obesity (Tomlin-
son et al., 2002). FGF-1 enhances adipogenesis of human 
preadipocytes and also supports development of the vas-
cular tissue within the fat pad (Hutley et al., 2004).Cell 131, October 19, 2007 ©2007 Elsevier Inc. 247
Hedgehog Signaling and GATA Transcription 
Factors
A potential role of Hedgehog signaling in mesoderm 
progression into adipose tissue was first suggested by 
developmental studies of Drosophila. In Drosophila, 
activation of the Hedgehog (Hh) pathway blocks forma-
tion of the fat body that is normally present during the 
larval and pupal periods (Suh et al., 2006), whereas the 
GATA transcription factor Serpent (srp), downstream of 
Hedgehog, is the earliest marker for fat body develop-
ment and is essential for its differentiation.
Mammalian homologs of Hedgehog, i.e., Sonic 
hedgehog (Shh), Indian hedgehog (Ihh), and Desert 
hedgehog (Dhh), strongly influence the fate of MSCs. 
During embryogenesis, Shh produced by the noto-
chord and neural tube exerts ventralizing influences 
on somitic cells controlling their fate into osteogenic, 
chondrogenic, myogenic, and presumably adipogenic 
lineages. Activation of the Hh pathway by Shh and Ihh 
can block the progression of mesenchymal C3H10T1/2 
cells to the adipogenic lineage, whereas inhibition of 
the Hh pathway with an antagonist of the Hh receptor 
smoothened (smo) or using a dominant-negative form 
of the downstream transcription factor Gli2 stimulates 
adipogenesis (Suh et al., 2006). This antiadipogenic 
action of Hh appears to be mediated by transcription 
factors of the GATA family. Constitutive expression of 
GATA-2 and GATA-3 suppresses differentiation of 3T3-
F442A preadipocytes. This occurs through the inter-
action between the GATAs and C/EBPα or C/EBPβ, 
resulting in suppression of PPARγ2 promoter activity 
(Tong et al., 2005). Conversely, embryonic stem cells 
lacking both copies of the GATA-3 gene demonstrate 
an enhanced capacity to differentiate into mature adi-
pocytes in vitro.
Wnt Signaling
Wnts are a 19-member family of secreted signaling 
proteins, which have a major influence on embryonic 
development and tumorogenesis. Wnt proteins bind 
to receptors of the frizzled family, which in turn acti-
vate β-catenin-dependent and β-catenin-independent 
actions. Although Wnt signaling is important in meso-
dermal development, once the MSC is formed Wnt 
acts to suppress adipogenic differentiation and favors 
myogenic or osteogenic differentiation. Overexpres-
sion of Wnt3a in C3H10T1/2 mesenchymal stem cells 
triggers differentiation of these cells toward osteo-
blasts and inhibits their ability to become adipocytes 
(Kennell and MacDougald, 2005), whereas condi-
tional deletion of β-catenin in the developing mouse 
uterus results in a switch from myogenesis to adipo-
genesis (Arango et al., 2005). Recently, BMP-2 has 
been shown to increase the expression of TAZ, a WW 
domain-containing transcriptional modulator, which 
acts similarly to β-catenin and modulates MSC fate 
favoring osteogenic gene transcription, while repress-
ing PPARγ-dependent adipogenic gene transcription 
(Hong et al., 2005).248 Cell 131, October 19, 2007 ©2007 Elsevier Inc.Sustained activation of the Wnt signaling pathway 
by overexpression of Wnt1, Wnt10b, or a β-catenin 
mutant with increased stability in mouse fibroblasts 
prevents adipogenic differentiation by blocking the 
cascade of gene expression regulated by C/EBPα and 
PPARγ. Mice overexpressing Wnt10b specifically in 
adipose tissue exhibit decreased total fat mass and 
increased bone mass (Longo et al., 2004). Interest-
ingly, in these mice, the interscapular BAT has a visual 
appearance of WAT but expresses neither brown nor 
white adipocyte markers. Conversely, myoblasts iso-
lated from Wnt10b-deficient mice show increased 
expression of genes involved in lipid storage and 
increased adipogenic potential (Vertino et al., 2005). 
Recently, a C256Y mutation in Wnt10b has been iden-
tified in a human subject with early-onset obesity 
(Christodoulides et al., 2006). This mutation abrogates 
Wnt10b’s ability to activate WNT signaling and block 
adipogenesis. Expression of Wnt10a and Wnt5a is 
also significantly increased in brown preadipocytes 
that are unable to differentiate due to impaired insulin 
signaling (Tseng et al., 2004, 2005), suggesting a dif-
ferential role of members of the Wnt family in the regu-
lation of brown versus white adipogenesis.
Adipocyte Heterogeneity among Different WAT 
Depots
The distribution of WAT not only varies considerably 
between species but also between individuals of the 
same species. In humans, variations of white fat dis-
tribution have gained considerable interest due to their 
association with metabolic disorders (Figure 1). There 
are two major, and not mutually exclusive, theories 
about why these different fat distributions are differ-
entially linked to metabolic complications. The first is 
based on anatomy and the fact that visceral fat drains 
its products (free fatty acids and various adipokines) 
into the portal circulation where they can act preferen-
tially on the liver to affect metabolism (Bjorntorp, 1990). 
The second is rooted in cell biology and is based on 
the concept that fat cells in different depots have dif-
ferent properties causing them to be linked to a greater 
or lesser extent to the development of metabolic disor-
ders (Lafontan and Berlan, 2003). Indeed, expression 
profiling has revealed significant differences in expres-
sion of hundreds of genes between different depots of 
adipose tissue in both rodents (Gesta et al., 2006) and 
humans (Vidal, 2001; Vohl et al., 2004). These differ-
ences may not only help explain the impact of different 
fat depots on the development of metabolic complica-
tions but also suggest possible differences in develop-
mental origin of these fat cells.
Differential origin of adipocytes in different WAT 
depots is also suggested by striking differences in adi-
pose tissue distribution among normal individuals and 
especially in individuals with various forms of lipodystro-
phy (Agarwal and Garg, 2006). For example, in congenital 
generalized lipodystrophy (Berardinelli-Seip Syndrome), 
adipose tissue is almost completely absent from subcu-
taneous depots, intra-abdominal depots, intrathoracic 
regions, and bone marrow. However, these individuals 
still have a relatively normal amount of adipose tissue in 
the retro-orbital area, buccal region, palms and soles, 
and other areas. In most families, this syndrome is due 
to mutations in seipin, a gene that encodes a 44 kDa 
protein of unknown function. By contrast, familial partial 
lipodystrophy of the Dunnigan type is due to mutations 
in the Lamin A/C gene and is characterized by a marked 
loss of subcutaneous adipose tissue in the extremities 
and trunk but no loss of visceral, neck, or facial adipose 
tissue. Some lipodystrophies appear to have a segmen-
tal or dermatomal distribution.
The notion that various WAT depots may be derived 
from distinct precursors is supported by a number of 
lines of evidence. First, different WAT depots have varia-
tions in chronology of appearance. In rodents, WAT 
develops mainly after birth, being present first in the 
perigonadal and subcutaneous depots, and only later in 
the omental depot. In humans, WAT development begins 
early in the second trimester of gestation and by birth is 
well developed in both the visceral and subcutaneous 
depots. Second, as noted above, visceral fat and sub-
cutaneous fat exhibit substantial differences in patterns 
of gene expression. Similarly, variations in gene expres-
sion have been observed in preadipocyte fractions from 
different adipose depots (Gesta et al., 2006). Likewise, 
administration of monoclonal antibodies raised against 
adipocyte plasma membranes to chick embryos signifi-
cantly reduces the weight of abdominal adipose tissue 
without affecting femoral or pectoral fat depots (Wu et 
al., 2000), suggesting that these depots express different 
membrane protein antigens than those of other depots. 
Third, these depot-specific variations in gene expres-
sion and adipose tissue function appear to be intrinsic 
(Hauner and Entenmann, 1991). Thus, isolated cloned 
human preadipocytes from subcutaneous adipose tis-
sue exhibit a greater ability to differentiate in culture than 
those from intra-abdominal adipose. These differences 
are conserved over multiple cell generations and are 
associated with different patterns of gene expression, 
suggesting that these adipose depots could result in part 
from different precursor cells (Tchkonia et al., 2006).
Some studies have also suggested that preadipocytes 
of obese humans replicate faster in culture than those of 
lean individuals and secrete more basic FGF (Lau et al., 
1987); however, this has not been observed in all studies 
(Permana et al., 2004). All of these studies are compli-
cated by the lack of distinct markers of the preadipocyte 
population and the difficulty defining precisely where in 
the commitment and differentiation process a given cell 
lies. Extrinsic factors may also differentially affect adi-
pocyte development in different depots. For example, 
transgenic mice overexpressing 11-β hydroxysteroid 
dehydrogenase in fat have the same level of enzyme 
in various fat depots but develop only visceral obesity 
(Masuzaki et al., 2001).Developmental and Patterning Genes in WAT 
Depots
The notion that developmental and patterning genes 
might play a role in the differential development of 
various adipose tissue depots has been suggested by 
several recent studies (Vohl et al., 2004; Cantile et al., 
2003; Gesta et al., 2006; Tchkonia et al., 2007). Intra-
abdominal adipocytes express higher levels of HoxA5, 
HoxA4, HoxC8, Glypican 4 (Gpc4), and Nr2f1 (nuclear 
receptor subfamily 2 group F member 1 or Coup-TF1), 
whereas subcutaneous fat has higher levels of HoxA10, 
HoxC9, Twist1, Tbx15, Shox2 (Short stature homeobox 
2), En1 (Engrailed 1), and Sfpr2, and in most cases, 
these differences are observed in both rodents and 
humans (Figure 4). Similar differences in development 
gene expression are observed in preadipocytes iso-
lated from different adipose depots of rodents (Gesta 
et al., 2006) and humans (Tchkonia et al., 2007), sug-
gesting that different regions of mesoderm might give 
rise to precursors in different adipose depots. These 
differences in gene expression are large in magnitude 
(up to 1000-fold), appear to be intrinsic, and persist 
during in vitro culture and differentiation, indicating that 
they are cell autonomous and independent of the tissue 
microenvironment. In addition, Gesta et al. (2006) have 
shown that three of these developmental genes (Tbx15, 
Glyp4, and HoxA5) exhibit changes in expression that 
closely correlate with the extent of obesity (BMI) and 
the pattern of fat distribution (WHR).
T-box15 (Tbx15) is a transcription factor from the 
phylogenetically conserved family of T-box genes. 
To date, 18 different mammalian T-box genes have 
been identified, many of which have orthologs in lower 
organisms. These T-box transcription factors share 
a characteristic sequence similarity within the DNA-
binding domain (T-domain). The first T-box gene char-
acterized was Brachyury (T), a gene known to play a 
major role in mesoderm development in vertebrates. 
In rodents, Tbx15 shows a dorsoventral patterning 
that mirrors the distribution of the agouti protein (Can-
dille et al., 2004), and loss of function of Tbx15 in mice 
results in abnormal skeletal development. In humans, 
Tbx15 is higher in visceral than in subcutaneous fat 
and correlates negatively with BMI and WHR in vis-
ceral adipose tissue and positively in subcutaneous 
adipose tissue (Gesta et al., 2006).
Glypican 4 (Gpc4) is a cell-surface heparan sulfate 
proteoglycan linked to the plasma membrane by a gly-
cosylphosphatidylinositol linkage. Glypicans can mod-
ify the activity of a number of morphogens and growth 
factors involved in mesodermal development, such as 
BMPs, Wnts, Hhs, and FGFs. In humans, visceral adi-
pose tissue Gpc4 expression correlates positively with 
both BMI and WHR, whereas in the subcutaneous adi-
pose tissue, the inverse is true (Gesta et al., 2006). In 
humans with the Simpson-Golabi-Behmel syndrome, 
part of the X chromosome carrying glypican 3 and 4 is 
deleted. These infants display macroglossia, macroso-Cell 131, October 19, 2007 ©2007 Elsevier Inc. 249
mia, and renal and skeletal abnormalities. Interestingly, 
fibroblasts from patients with the Simpson-Golabi-Beh-
mel syndrome show an increased tendency to differenti-
ate into adipocytes in culture (Wabitsch et al., 2001).
Hox genes encode conserved transcription factors 
expressed along the anteroposterior axis of vertebrates 
and serve as determinants of embryonic cell fate. These 
genes share a 180 bp homeobox that encodes a 60 
amino acid DNA-binding homeodomain and are orga-
nized in 4 clusters (HoxA, HoxB, HoxC, and HoxD). Dis-
ruption of HoxA5 gene in mice causes early postnatal 
lethality due to respiratory tract defects. However, sur-
viving animals present diverse skeletal and gastroinst-
estinal abnormalities (Aubin et al., 2002). HoxA5 expres-
sion positively correlates with BMI and WHR in both 
visceral and subcutaneous human WAT (Gesta et al., 
2006). Thus, HoxA5, Gpc4, and Tbx15 expression vary 
with fat distribution and expression of the latter two is an 
excellent marker for visceral fat accumulation.
Potential Heterogeneity within a Single Fat depot
In addition to differences between fat cells in adipose 
tissue depots, recent work has suggested that there 
may be heterogeneity of adipocytes and preadipo-
cytes within the same depots (Figure 5). Mice with 
fat-specific knockout of the insulin receptor (FIRKO) 
or hormone-sensitive lipase (HSL) exhibit a heteroge-
neous phenotype in adipocytes, with two populations 
of adipocytes—one with a small diameter (<50 µm) and 
the other having a large diameter (>150 µm)—rather 
than a normal distribution of size (Bluher et al., 2002; 
Figure 5. Evidence for Heterogeneity of Preadipocytes and 
Adipocytes
Evidence for two distinct subtypes of preadipocytes in human sub-
cutaneous fat can be found in differences in replication rates, differ-
entiation capacities, and susceptibilities to TNF-α-induced apoptosis 
(Tchkonia et al., 2005). Preadipocytes isolated from different regions 
of the body show differential patterns of gene expression and capabil-
ity in differentiation (Gesta et al., 2006). The presence of heterogene-
ity of adipocytes is also suggested by a bimodal size distribution in 
cells isolated from mice with fat-specific knockout (KO) of the insulin 
receptor (IR) (Bluher et al., 2002) or hormone-sensitive lipase (HSL) 
(Fortier et al., 2005), from Zucker rats treated with thiazolidinediones 
(TZD) (de Souza et al., 2001), and by differences in gene and protein 
expression between large and small adipocytes.250 Cell 131, October 19, 2007 ©2007 Elsevier Inc.Fortier et al., 2005). Characterization of the smaller and 
larger cells from both FIRKO and normal mice (Bluher et 
al., 2004) and from normal humans (Jernas et al., 2006) 
reveals differences in expression of several genes and 
proteins, supporting the hypothesis that a single fat 
pad may contain at least two populations. Furthermore, 
in mice, the response of adipocytes in a single depot 
to a treatment with thiazolidinedione, an antidiabetic 
drug and ligand of PPARγ, suggests the presence of at 
least two populations of different diameters (de Souza 
et al., 2001). More recently, Tchkonia et al. (2005) have 
produced more direct evidence of developmental het-
erogeneity by studying preadipocytes cloned from a 
single human fat depot. They found two distinct types 
of clones—one exhibiting higher expression of adipo-
genic transcription factors and better ability to replicate 
and differentiate but less sensitive to TNF-α induced 
apoptosis than the other type. The proportion of these 
preadipocyte subtypes differed between the different 
depots studied. Thus, analogous to the situation with 
white blood cells in various organs, different depots 
of adipose tissue may contain variable ratios of differ-
ent types of white adipocytes resulting from separate 
developmental lineages. This could play an important 
mechanistic role linking different forms of obesity to 
metabolic diseases and also opens new possibilities 
for finding therapeutic targets or pathways to treat obe-
sity and obesity-associated complications.
Specifying Brown versus White Adipose Lineages
The developmental patterns of BAT and WAT are also 
distinct. BAT emerges earlier than WAT during fetal 
development. It is at its maximal size relative to body 
weight at birth, when the requirements for nonshiver-
ing thermogenesis are needed, then involutes in both 
humans and rodents with aging (Cannon and Neder-
gaard, 2004). Development of WAT, on the other hand, 
begins in midgestation (in humans) or shortly after 
birth (in rodents) and gradually increases throughout 
life. Morphologically, BAT can be distinguished from 
WAT by multilocular lipid inclusions, rich vasculariza-
tion, and abundant mitochondrial density.
Many genes are differentially expressed in mature 
brown and white adipocytes (Figure 4). With the 
exception of UCP-1, which is generally accepted as 
the defining marker of brown fat, most other differen-
tially expressed genes show only relative differences 
between the two types of adipose cells. These include 
the cell death-inducing DFF45-like effector A (Cidea), 
which is highly expressed in BAT, where it interacts 
with and suppresses UCP-1 activity; type 2 iodothy-
ronine deiodinase; the transmembrane glycoprotein 
Cig30; the fatty-acid-activated transcription factor 
PPARα; the nuclear coactivator PGC-1α; and factors 
involved in mitochondrial biogenesis and function. All 
of these genes are preferentially expressed in BAT, 
whereas leptin, the nuclear corepressor RIP140, and 
the matrix protein fibrillin-1 are more highly expressed 
in WAT than BAT. Among the developmental genes, 
homeobox genes HoxA1 and HoxC4 are preferentially 
expressed in human fetal BAT, whereas HoxA4 and 
HoxC8 are more abundant in human WAT (Figure 4; 
Table S1).
At the cellular level, both BAT and WAT appear to 
originate from mesodermal/mesenchymal stem cells 
(Figure 4). One important and unsolved question 
in adipocyte biology relates to defining exactly how 
and when the differentiation of BAT versus WAT is 
specified. Most data indicate that white and brown 
preadipocytes are already committed to their unique 
differentiation fates. Thus, stromovascular fractions 
containing preadipocytes isolated from BAT differ-
entiate into UCP-1-expressing cells, whereas similar 
isolates from WAT differentiate into fat without UCP-1 
(Kopecky et al., 1990). In addition, lineage tracking 
studies using the UCP-1 promoter have demonstrated 
that white adipocytes are distinct from brown adipo-
cytes during normal development (Moulin et al., 2001). 
Indeed, brown preadipocytes have been reported to 
possess a “myogenic” signature, providing additional 
evidence for distinct origins of BAT and WAT and a 
potential link to the energy-burning function of BAT 
(Timmons et al., 2007). However, in rodents chronically 
exposed to cold, many white fat depots develop large 
numbers of brown fat cells (Cinti, 2005), and low levels 
of UCP-1 can be found in SVF isolated from WAT dur-
ing in vitro differentiation (Klaus et al., 1995). Whether 
this represents transdifferentiation of WAT adipocytes 
or preadipocytes to BAT or simply the presence of 
brown preadipocytes in many WAT depots is unknown, 
but the stable nature of white and brown preadipocyte 
cell lines in culture suggests the latter is more likely 
the case.
Factors Involved in Brown versus White Lineage 
Determination
Preadipocytes need to be released from suppression to 
become committed to terminal differentiation. Among 
the known inhibitors of this early adipogenic event, 
several have differential effects on brown versus white 
fat differentiation, including members of the Wnt and 
retinoblastoma families. These include pRB, p107, and 
p130, which selectively suppress the differentiation of 
brown preadipocytes via repression of the transcription 
factor FOXC2 and coactivator PGC-1α (Table S2). Nec-
din, a protein functionally resembling pRB as a growth 
suppressor, is also highly expressed in brown preadi-
pocytes (Boeuf et al., 2001), and suppression of necdin 
by insulin may be essential for brown preadipocytes 
to enter an adipogenic program (Tseng et al., 2005). 
Recently, a zinc finger-containing protein, PRDM16, 
has been found selectively expressed in brown fat 
cells. Forced expression of prdm16 in a white preadi-
pocyte cell line or WAT in vivo activates a robust brown 
fat phenotype (Seale et al., 2007). However, the major 
regulators determining brown versus white preadipo-
cyte commitment remain to be determined.Similar to white adipocytes, the differentiation of 
brown preadipocytes to brown adipocytes is controlled 
by a transcriptional cascade involving the transcrip-
tion factors C/EBPs and PPARγ. Interestingly, however, 
some of these adipogenic transcription factors appear 
to have differential effects on brown versus white fat 
differentiation. Thus, mice lacking C/EBPα in all tissues 
but liver display a complete absence of WAT, whereas 
interscapular BAT is nearly normal (Linhart et al., 2001). 
Conversely, mice with adipose-specific knockout of 
PPARγ display marked reduction in both WAT and BAT 
(He et al., 2003). Recently, Gray et al. (2006) reported 
that a dominant-negative PPARγ mutation (P465L) dis-
plays altered brown fat morphology with larger lipid 
droplets, leading to reduced thermogenic capacity, 
while WAT appears to be normal.
Factors that Control the Thermogenic Program  
of BAT
BAT is uniquely distinguished from WAT and other tis-
sues by its function in thermogenic energy expendi-
ture. A number of transcription factors and coregula-
tors appear to play particularly important roles in the 
final stages of differentiation of BAT and modulation 
of the expression of thermogenic genes, especially 
UCP-1. Among these, PGC-1α appears to have a cen-
tral role by enhancing the transcriptional activity of 
PPARγ and the thyroid hormone receptor (Puigserver 
et al., 1998). Indeed, ectopic expression of PGC-1α in 
white preadipocytes can activate expression of UCP-1 
and key components of the mitochondrial respiratory 
chain (Tiraby et al., 2003). Brown preadipocytes lack-
ing PGC-1α show reduced induction of thermogenic 
genes but differentiate normally, suggesting that 
PGC-1α is important for the thermogenic function 
of brown fat but is dispensable for induction of lipid 
accumulation (Uldry et al., 2006).
Several other factors modulate brown versus white 
differentiation via regulation of expression or activity 
of PGC-1α (Table S2) (Hansen and Kristiansen, 2006). 
FOXC2, CREB, SIRT3, SRC-1, and p/CIP, as well as intra-
cellular messengers, such as nitric oxide and p38 MAP 
kinase, are known to positively regulate PGC-1α gene 
transcription; whereas repressors of transcription, such 
as pRB, necdin, p107, TIF2, SHP, and LXR, suppress 
expression of PGC-1α. In addition, the translational inhibi-
tor 4E-BP1 specifically represses translation of PGC-1α 
mRNA, thereby inhibiting brown adipogenesis. Activity 
of PGC-1α can also be regulated posttranslationally. For 
example, p38 MAP kinase can directly phosphorylate 
PGC-1α protein and enhance its transcriptional activity 
in brown fat. Ultimately, docking of PGC-1α to transcrip-
tion factors, such as PPARγ, thyroid hormone receptor, 
NRF-1, and PPARδ, stimulates a conformational change 
in PGC-1α that permits binding of other nuclear activa-
tors, such as SRC-1 and CBP/p300, leading to a great 
increase of transcription of target genes. Conversely, the 
p160 myb-binding proteins are able to suppress the activ-
ity of PGC-1α via a p38MAP kinase-dependent pathway.Cell 131, October 19, 2007 ©2007 Elsevier Inc. 251
There are also important PGC-1α-independent 
mechanisms involved in the controls of UCP-1 expres-
sion and/or mitochondrial biogenesis. For example, the 
nuclear corepressor RIP140 is expressed at high lev-
els in WAT where it suppresses oxidative metabolism 
and mitochondrial biogenesis (Powelka et al., 2006). 
RIP140 knockout mice are lean and show significantly 
increased mitochondrial oxidative phosyphorylation 
and UCP-1 expression in WAT depots (Leonardsson 
et al., 2004). In contrast, the cell death-inducing fac-
tor, Cidea, is expressed at high levels in BAT, where 
it directly interacts with UCP-1 and suppresses its 
activity. Cidea null mice are resistant to obesity and 
have a higher metabolic rate in BAT and higher body 
temperature when exposed to cold as compared with 
wild-type mice (Zhou et al., 2003).
Hormonal/Environmental Control of Fat Cell 
Differentiation
In addition to the many hormones that are known to 
induce both white and brown adipocyte differentiation, 
brown and white adipocyte development and func-
tion are also influenced by many extrinsic factors. The 
extracellular matrix plays important differential roles in 
brown and white adipocyte differentiation. Thus, mice 
lacking the membrane-type 1 matrix metalloproteinase 
display a selective absence of WAT, but not BAT (Chun 
et al., 2006). In rodents, the autonomic nervous system 
has opposing roles in the recruitment/development of 
BAT and WAT. The differentiation of brown preadipo-
cytes is strongly stimulated by adrenergic agents such 
as norepinephrine, whereas both proliferation and dif-
ferentiation of white preadipocytes increases following 
sympathetic denervation (Cousin et al., 1993). Adrener-
gic stimulators promote proliferation and differentiation 
of brown preadipocytes, protect mature brown adipo-
cytes from apoptosis, and enhance the thermogenic 
capacity of BAT via induction of UCP-1 gene expression 
(Cannon and Nedergaard, 2004). Cold exposure and 
feeding increase BAT activity and UCP-1 expression via 
norepinephrine released from the sympathetic nervous 
system. Other stimuli can induce UCP-1 expression, 
including thyroid hormone, insulin, thiazolidinediones, 
retinoic acid, cAMP analogs, and β-adrenergic ago-
nists (Diehl and Hoek, 1999). Bile acids can increase 
whole-body energy expenditure by promoting intrac-
ellular thyroid hormone activation in BAT and muscle 
(Watanabe et al., 2006). Conversely, glucocorticoids 
inhibit UCP-1 gene expression in response to adrener-
gic stimulation.
Plasticity and Regenerative Capacity of Adipose 
Tissue
As in all tissues, cells in adipose tissue have a natural 
life cycle. Although the precise rate of turnover of fat 
cells is not know, recent studies have demonstrated 
that white fat pads may contain dead or dying adipo-
cytes that are often surrounded by macrophages that 252 Cell 131, October 19, 2007 ©2007 Elsevier Inc.phagocytose the lipid droplets and ultimately form 
multinucleate giant cells (Cinti et al., 2005). Adipocyte 
necrosis increases in obese humans and mice up to 
30-fold. Apoptosis of adipocytes and preadipocytes 
can also be increased by treatment of cells with cytok-
ines such as TNFα. Genetically engineered mice in 
which caspase 8 activation in fat is made drug induc-
ible exhibit massive apoptosis of adipocytes (Pajvani 
et al., 2005). Interestingly, within weeks after cessation 
of the drug treatment, there is a remarkable regrowth 
of fat to nearly normal levels, indicating the potential 
for preadipocytes to regenerate new adipocytes.
Plasticity of BAT and WAT remains a controversial 
issue. In both rodents and humans, BAT depots are 
replaced by WAT during aging. Conversely, brown adi-
pocytes are observed in classical white fat depots, 
and their number increases dramatically during cold 
adaptation or after hormonal and/or pharmacologi-
cal treatments, such as β3 adrenoceptor agonist, 
retinoic acid, thiazolidinediones, and leptin adminis-
tration (Diehl and Hoek, 1999). Although these find-
ings may represent transformation of white adipose 
to brown and vice versa, based on the data reviewed 
above, it seems more likely that the UCP-1-express-
ing brown adipocytes observed in WAT under these 
conditions come from recruitment and differentiation 
of mesenchymal progenitor cells or brown preadipo-
cytes within the WAT. Indeed, the stromovascular frac-
tion is a heterogeneous cell population and appears 
to contain pluripotent cells capable of differentiating 
into multiple cell lineages, including cells of mesoder-
mal lineage (adipocytes, osteoblasts, chondrocytes, 
myocytes), cells of endodermal lineage (endothelial 
cells and hepatocytes) (Fraser et al., 2006), and cells 
of neuroectodermal lineage (neuronal cells and insu-
lin-producing cells) (Timper et al., 2006). In rodents, 
stromovascular fractions derived from subcutaneous 
inguinal WAT exhibit a greater potential to differentiate 
into multiple lineages than those derived from intra-
abdominal fat (Prunet-Marcassus et al., 2005).
Perspective
The adipose organ is complex, with multiple com-
partments composed of cells with different functions 
that most likely arise from different developmental 
lineages. Although the field of adipocyte biology has 
made great progress, we still lack markers capable 
of distinguishing MSC from preadipocytes that can 
define various stages in the differentiation process or 
that can identify preadipocytes with different devel-
opmental potentials. Although it is likely that brown 
and white preadipocytes are already determined in 
their lineage, controlling the numbers of each of these 
cell populations and their depot-specific differentia-
tion could provide new treatments for obesity and 
its complications. With this approach, we could truly 
track the current epidemic of obesity to its develop-
mental origins.
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